A review of the clinical evidence supporting DormoVision X™ Home PSG and In-Lab PSG devices, with a focus on oxygen saturation accuracy, forehead sensor technology, and performance across different skin tones and sleeping positions.
Summary
This article reviews the validation studies supporting the photoplethysmography technology incorporated in DormoVision X™ Home PSG and DormoVision X™ In-Lab PSG devices. The validation procedures assessed oxygen-saturation performance against established reference methods across normal and reduced oxygen levels, different skin tones, and body positions.
The results demonstrated agreement with the gold standard arterial reference, with no systematic pigmentation related performance differences reported. Positional testing provided further evidence of measurement agreement across the evaluated postures. Together with the existing scientific literature, these findings provide a clinical foundation for confidence in oxygen-saturation monitoring with
DormoVision X™ Home PSG and DormoVision X™ In-Lab PSG across physiological conditions.
Clinical Validation Framework for DormoVision X™ SpO₂ Measurement
The DormoVision X™ Platform incorporates photoplethysmography (PPG) technology for recording oxygen saturation and pulse rate alongside comprehensive physiological sleep signals. Its pulse oximetry technology is supported by a dedicated clinical validation program combining arterial reference accuracy testing with additional assessment across body positions. These complementary studies evaluated performance across normal and reduced oxygen levels, different skin tones, and positions relevant to sleep assessment [1–3].
The studies were conducted by a specialist clinical testing laboratory with expertise in pulse oximeter validation (Vital Signs Research Group, San Francisco https://vitalsignsresearchgroup.com ), using prospective protocols with ethics committee approval and informed consent. The reports describe testing conducted in accordance with ISO 14155 and ISO 80601-2-61, providing a structured framework for clinical investigation and pulse oximeter performance assessment [2, 3].
The dedicated oxygen saturation studies collected 633 paired measurements from 22 subjects, evaluating performance across oxygen saturation levels spanning 70-100%, different skin tones, and body positions.
Assessment included root-mean-square error (RMSE), mean bias, and limits of agreement against the respective reference methods [2, 3]. Beyond this dedicated oximetry testing, the platform’s broader clinical validation program included studies enrolling 73 additional participants (47 adults and 26 children) to evaluate comprehensive physiological sleep measurements against reference polysomnography [4, 5].
Additional support for the platform’s clinical performance comes from published validation of its earlier recording system against Nox A1 polysomnography. In the study, AHI severity classification agreed in 97.6% of fully analyzed recordings, with Cohen’s κ of approximately 0.97, supporting the platform’s broader capability for comprehensive sleep assessment [4].
Clinical Evidence for the Forehead Oxygen Saturation Sensor
Pulse oximetry estimates arterial oxygen saturation from the differential absorption of red and infrared light by oxygenated and deoxygenated hemoglobin. The pulsatile component helps distinguish arterial blood-volume changes from the surrounding tissue signal. This principle can be implemented using transmission geometry, commonly at the finger, or reflectance geometry, as used at the forehead [6].
Forehead reflectance oximetry is an established clinical approach. Its validity depends on the complete sensor system including optical design, fixation, calibration, and processing and is demonstrated through comparison with an appropriate reference. For DormoVision X™ Home PSG and In-Lab PSG, that evidence includes testing the sensor in its intended forehead location against arterial blood measurements [2].
Clinical research identifies several reasons why forehead measurement can be useful:
- Performance during reduced peripheral perfusion. Under vasoconstrictive conditions associated with severe shock and high-dose vasopressor treatment, forehead oximetry produced fewer errors than finger oximetry: 15% versus 32% of measurements differed from arterial blood saturation by more than three percentage points, with the finger sensor failing to provide readings in four patients [7].
- Higher temporal precision in detecting oxygenation changes. During induced oxygenation changes in anesthetized patients, forehead reflectance oximetry detected desaturation and resaturation earlier than finger transmission oximetry, supporting higher temporal precision in tracking these changes. The forehead sensor detected the decline to 95% SpO₂ 12 seconds earlier, based on the difference in median response times [8].
- Reduced artifacts during overnight monitoring. In simultaneous recordings from 41 patients undergoing polysomnography, forehead oximetry had the fewest artifact occurrences, while finger oximetry had the most signal dropouts [9].
SpO₂ Accuracy Across Skin Tones
The PPG of DormoVision X™ Home PSG and In-Lab PSG underwent dedicated clinical validation for the assessment of SpO₂ accuracy across all skin tones range. The study compared sensor measurements directly with arterial blood oxygen saturation, providing device-specific evidence of performance across the pigmentation range evaluated [1, 2].
Skin pigmentation was explicitly addressed in the study design through:
- Broad representation of skin tones. Participants represented Fitzpatrick skin types I–VI, ranging from very fair to deeply pigmented skin. Skin characteristics were additionally documented using the Monk Skin Tone Scale and Individual Typology Angle, supporting assessment of pigmentation beyond ethnicity alone.
- Assessment across normal and reduced oxygen levels. Sensor readings were compared with arterial measurements across 70-100% oxygen saturation, extending the evaluation beyond normal resting oxygen levels [2].
| Skin-pigmentation group | Reported SpO2 RMSE |
|---|---|
| Light | 3.18 percentage points |
| Medium | 2.53 percentage points |
| Dark | 1.57 percentage points |
SpO₂ Performance Across Body Positions
The PPG of DormoVision X™ Home PSG and In-Lab PSG underwent dedicated clinical testing to evaluate SpO₂ performance across different sleeping positions. A prospective study compared DormoVision X™ Home PSG and In-Lab PSG readings with a Nonin 7500 finger pulse oximeter, providing device specific evidence of measurement agreement across the positions evaluated [3].
The study addressed positional performance through:
- Assessment across common sleeping positions. Ten healthy volunteers were tested while lying prone, on their side, and supine, representing three common sleeping positions.
- Testing across normal and reduced oxygen levels. Measurements were collected during controlled, stable oxygen-saturation plateaus spanning 70–100%, extending the assessment beyond normal resting oxygen levels.
- Additional assessment after positional changes. Eight participants also provided measurements after moving to seated and standing positions, at oxygen-saturation levels within the 90–100% range.
Across 374 paired measurements, the overall difference between the reference oximeter and DormoVision X™ Home PSG and In-Lab PSG corresponded to an RMSE of 2.96 percentage points. Among sleeping positions, the lowest RMSE was 2.23 percentage points in the prone position. Position-specific results are presented in Table 2 [3].
| Position | Paired measurements | Evaluated saturation range | Reported RMSE |
|---|---|---|---|
| Prone | 127 | 70–100% | 2.23 percentage points |
| Side | 122 | 70–100% | 3.73 percentage points |
| Supine | 109 | 70–100% | 3.02 percentage points |
| Seated | 8 | 90–100% | 1.73 percentage points |
| Standing | 8 | 90–100% | 1.17 percentage points |
| Overall | 374 | 70–100% | 2.96 percentage points |